148 related articles for article (PubMed ID: 9832397)
1. Neuroprotective effect of 5-HT1A receptor agonist, Bay X 3702, demonstrated in vitro and in vivo.
Semkova I; Wolz P; Krieglstein J
Eur J Pharmacol; 1998 Oct; 359(2-3):251-60. PubMed ID: 9832397
[TBL] [Abstract][Full Text] [Related]
2. S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702.
Ahlemeyer B; Beier H; Semkova I; Schaper C; Krieglstein J
Brain Res; 2000 Mar; 858(1):121-8. PubMed ID: 10700604
[TBL] [Abstract][Full Text] [Related]
3. The 5-HT1A receptor agonist Bay x 3702 inhibits apoptosis induced by serum deprivation in cultured neurons.
Ahlemeyer B; Glaser A; Schaper C; Semkova I; Krieglstein J
Eur J Pharmacol; 1999 Apr; 370(2):211-6. PubMed ID: 10323272
[TBL] [Abstract][Full Text] [Related]
4. The 5-HT1A receptor agonist BAY x 3702 prevents staurosporine-induced apoptosis.
Suchanek B; Struppeck H; Fahrig T
Eur J Pharmacol; 1998 Aug; 355(1):95-101. PubMed ID: 9754943
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo.
Mauler F; Fahrig T; Horváth E; Jork R
Brain Res; 2001 Jan; 888(1):150-157. PubMed ID: 11146061
[TBL] [Abstract][Full Text] [Related]
6. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF.
Semkova I; Schilling M; Henrich-Noack P; Rami A; Krieglstein J
Brain Res; 1996 Apr; 717(1-2):44-54. PubMed ID: 8738252
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus properties of the 5-HT1A receptor agonist BAY x 3702 in the rat.
De Vry J; Jentzsch KR
Eur J Pharmacol; 1998 Sep; 357(1):1-8. PubMed ID: 9788767
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
9. Oral post-lesion administration of 5-HT(1A) receptor agonist repinotan hydrochloride (BAY x 3702) attenuates NMDA-induced delayed neuronal death in rat magnocellular nucleus basalis.
Harkany T; Mulder J; Horvath KM; Keijser J; van der Meeberg EK; Nyakas C; Luiten PG
Neuroscience; 2001; 108(4):629-42. PubMed ID: 11738499
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of cortical and hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by BAY x 3702 in freely moving rats.
Koyama T; Nakajima Y; Fujii T; Kawashima K
Neurosci Lett; 1999 Apr; 265(1):33-6. PubMed ID: 10327199
[TBL] [Abstract][Full Text] [Related]
11. In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release.
Casanovas JM; Berton O; Celada P; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):248-54. PubMed ID: 10997727
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of 5-HT(1A) receptors reduces apoptosis after transient forebrain ischemia in the rat.
Schaper C; Zhu Y; Kouklei M; Culmsee C; Krieglstein J
Brain Res; 2000 Nov; 883(1):41-50. PubMed ID: 11063986
[TBL] [Abstract][Full Text] [Related]
13. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage.
Semkova I; Wolz P; Schilling M; Krieglstein J
Eur J Pharmacol; 1996 Nov; 315(1):19-30. PubMed ID: 8960860
[TBL] [Abstract][Full Text] [Related]
14. The neuroprotective effect of a new serotonin receptor agonist, BAY X3702, upon focal ischemic brain damage caused by acute subdural hematoma in the rat.
Alessandri B; Tsuchida E; Bullock RM
Brain Res; 1999 Oct; 845(2):232-5. PubMed ID: 10536203
[TBL] [Abstract][Full Text] [Related]
15. Effects of serotonergic drugs in experimental brain ischemia: evidence for a protective role of serotonin in cerebral ischemia.
Prehn JH; Welsch M; Backhauss C; Nuglisch J; Ausmeier F; Karkoutly C; Krieglstein J
Brain Res; 1993 Dec; 630(1-2):10-20. PubMed ID: 8118677
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury.
Mauler F; Horváth E
J Cereb Blood Flow Metab; 2005 Apr; 25(4):451-9. PubMed ID: 15674237
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of 5-HT1A receptor agonists against neuronal damage demonstrated in vivo and in vitro.
Peruche B; Backhauss C; Prehn JH; Krieglstein J
J Neural Transm Park Dis Dement Sect; 1994; 8(1-2):73-83. PubMed ID: 7893378
[TBL] [Abstract][Full Text] [Related]
18. Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; de Montigny C; Blier P
J Pharmacol Exp Ther; 1998 Sep; 286(3):1239-47. PubMed ID: 9732384
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
[TBL] [Abstract][Full Text] [Related]
20. The selective 5-HT(1A) receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats.
Kline AE; Yu J; Horváth E; Marion DW; Dixon CE
Neuroscience; 2001; 106(3):547-55. PubMed ID: 11591455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
